Literature DB >> 17533005

Role of chemokines for the localization of leukocyte subsets in the kidney.

Stephan Segerer1, Detlef Schlöndorff.   

Abstract

Chemokines comprise a family of structurally related chemotactic proteins. They bind to about 20 corresponding receptors. Chemokines provide a general communication system for cells, and regulate lymphocyte migration under normal (homeostatic) and inflammatory conditions. Chemokines organize microenvironments in lymphoid tissue, lymphoid organogenesis, and participate in vascular and lymphatic angiogenesis. Expressed at the site of injury in the kidney, chemokines are involved in the recruitment of specific leukocyte subsets to particular renal compartments. Here we summarize recent data on chemokine biology with a focus on the role of chemokines in the recruitment of neutrophils (polymorphonuclear leukocytes), monocytes/macrophages, dendritic cells, T cells, including regulatory T cells, and B cells in renal inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533005     DOI: 10.1016/j.semnephrol.2007.02.003

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  16 in total

1.  Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure.

Authors:  Prasad R Konkalmatt; Laureano D Asico; Yanrong Zhang; Yu Yang; Cinthia Drachenberg; Xiaoxu Zheng; Fei Han; Pedro A Jose; Ines Armando
Journal:  JCI Insight       Date:  2016-06-02

2.  Connections in chronic kidney disease: connexin 43 and connexin 37 interaction.

Authors:  Pedro A Jose; Shiyou Chen; Ines Armando
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-27

Review 3.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

4.  CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis.

Authors:  D Petrovic-Djergovic; M Popovic; S Chittiprol; H Cortado; R F Ransom; S Partida-Sánchez
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

5.  Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.

Authors:  Yanrong Zhang; Xiaoliang Jiang; Chuan Qin; Santiago Cuevas; Pedro A Jose; Ines Armando
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

Review 6.  The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.

Authors:  FuNien Tsai; Harris Perlman; Carla M Cuda
Journal:  Clin Immunol       Date:  2016-10-22       Impact factor: 3.969

7.  Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis.

Authors:  L M McIntosh; J L Barnes; V L Barnes; J R McDonald
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

8.  Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines.

Authors:  Volker Vielhauer; Ramanjaneyulu Allam; Maja T Lindenmeyer; Clemens D Cohen; Dan Draganovici; Jana Mandelbaum; Nuru Eltrich; Peter J Nelson; Hans-Joachim Anders; Monika Pruenster; Antal Rot; Detlef Schlöndorff; Stephan Segerer
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

Review 9.  T cell cross-talk with kidney dendritic cells in glomerulonephritis.

Authors:  Ulf Panzer; Christian Kurts
Journal:  J Mol Med (Berl)       Date:  2009-10-02       Impact factor: 4.599

10.  The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis.

Authors:  Hans-Joachim Paust; Jan-Eric Turner; Oliver M Steinmetz; Anett Peters; Felix Heymann; Christoph Hölscher; Gunter Wolf; Christian Kurts; Hans-Willi Mittrücker; Rolf A K Stahl; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.